| COPD | fILD | LC | ||||||
---|---|---|---|---|---|---|---|---|---|
RM (nâ=â336) | PC (nâ=â95) | Specialties compared (Ï2) p value | RM (nâ=â324) | PC (nâ=â87) | Specialties compared (Ï2) p value | RM (nâ=â300) | PC (nâ=â102) | Specialties compared (Ï2) p value | |
Drug treatment for breathlessness | 70 (21%) | 52 (55%) | pâ<â0.001 | 78 (24%) | 35 (40%) | pâ<â0.001 | 174 (58%) | 76 (75%) | pâ=â0.001 |
Re-assess oxygen prescription | 29 (9%) | 2 (2%) | 79 (24%) | 3 (3%) | 23 (8%) | 1 (1%) | |||
Non-pharmacological, non-exercise intervention | 28 (8%) | 25 (26%) | 28 (9%) | 24 (28%) | 29 (10%) | 15 (15%) | |||
Exercise training / rehabilitation | 166 (49%) | 7 (7%) | 96 (30%) | 16 (18%) | 10 (3%) | 1 (1%) | |||
Psychological assessment to explore co-existing anxiety and/or depression | 31 (9%) | 5 (5%) | 30 (9%) | 6 (7%) | 58 (19%) | 7 (7%) | |||
Other | 12 (4%) | 4 (4%) | 13 (4%) | 3 (3%) | 6 (2%) | 2 (2%) |